Skip to main content

Division of Allergy Pulmonary and Critical Care Medicine Archives

Study finds administering IV fluids during emergency tracheal intubation does not lower cardiac arrest risk

Jun. 20, 2022—Rapidly administering IV fluids to critically ill adults undergoing emergency tracheal intubation does not significantly decrease chances of hypotension (low blood pressure) and cardiac arrest, a Vanderbilt University Medical Center-led study shows.

Read more


Study explores positioning options to improve COVID mortality

Jun. 2, 2022—Vanderbilt researchers found that prone positioning of patients with COVID-19-related hypoxemia not on mechanical ventilation offered no observed clinical benefit among these patients.

Read more


ICU study confirms safety of delabeling penicillin allergies

Mar. 10, 2022—A Vanderbilt study shows that physicians can safely identify and disprove low-risk penicillin allergies using an oral amoxicillin challenge in consenting patients, even those in the intensive care unit who are recovering from critical illness.

Read more


New Clinician Spotlight: Michael Lester

Jan. 11, 2022—Michael Lester, MD, has joined Vanderbilt University Medical Center after completing seven years of internship, residency and fellowship here.

Read more


Alarming number of pregnant COVID-19 patients hospitalized in August

Sep. 1, 2021—Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).

Read more


New Clinician Spotlight: Katie McPherson

Jul. 2, 2021—Katie McPherson, MD, assistant professor of Medicine, has joined Vanderbilt University Medical Center after completing a fellowship in pulmonary and critical care medicine at the University of Colorado in Aurora.

Read more


Type 2 diabetes medication shown to benefit asthma patients

May. 20, 2021—Type 2 diabetes patients who also have asthma are benefitting from a diabetes medication, typically given to help the pancreas produce more insulin, that also improves asthma symptoms and may reduce lung and airway inflammation.

Read more


Vanderbilt mourns loss of pulmonary medicine pioneer Richard Light

May. 17, 2021—Richard Light, MD, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care, died May 11 from injuries he sustained from a fall. He was 79.

Read more


Vanderbilt mourns the passing of Pierre Massion

Apr. 6, 2021—Pierre Massion, MD, Cornelius Vanderbilt Chair and Professor of Medicine, an internationally known expert on early detection and prevention strategies for lung cancer, died April 4 of an apparent heart attack. He was 58.

Read more


Team studies new use for pulmonary hypertension drug

Mar. 25, 2021—An FDA-approved medication enhances the function of T regulatory cells (Treg), a class of immune cells that restrains the immune response, Vanderbilt investigators have discovered.

Read more


Device offers less invasive option to treat emphysema

Feb. 4, 2021—Life with emphysema, a lung condition that causes shortness of breath, can be miserable. People with advanced emphysema, a form of chronic obstructive pulmonary disease (COPD), are so short of breath they may need supplemental oxygen just to walk from room to room. They often have trouble with everyday tasks like bathing or cooking a meal.

Read more


Rice named to new leadership role for VICTR operations

Jul. 23, 2020—Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more